In glioma, it was found that ALKBH5 not only affected tumor invasion ability, but also mediated tumor radioresistance, and the knockdown of ALKBH5 could play an active role in the treatment of glioma and improve its sensitivity to radiation therapy [247]. The gene discussed is ALKBH5; the disease is central nervous system cancer.